About Hospital Das Clinicas Da Universidade Federal de Goias
"Hospital das Clínicas de Goiânia"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Hospital Das Clinicas Da Universidade Federal de Goias
During the past decade, Hospital Das Clinicas Da Universidade Federal de Goias conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 7 clinical trials were completed, i.e. on
average, 35% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 7 clinical trials were completed. i.e. 53.8%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital Das Clinicas Da Universidade Federal de Goias" #1 sponsor was "United Therapeutics" with 4 trials, followed by "Actelion" with 3 trials
sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored and "Bayer"
with 3 trials sponsored. Other sponsors include 4 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Das Clinicas Da Universidade Federal de Goias"
#1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Actoverco" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Innogene Kalbiotech Pte. Ltd" with 1 trials as a collaborator and "Key Oncologics (Pty) Ltd" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were
collaborators in the rest 11 trials.
Clinical Trials Conditions at Hospital Das Clinicas Da Universidade Federal de Goias
According to Clinical.Site data, the most researched conditions in "Hospital Das Clinicas Da Universidade Federal de Goias" are
"Pulmonary Arterial Hypertension" (5 trials), "Cardiovascular Diseases" (3 trials), "Heart Failure" (3 trials), "Multiple Myeloma" (3 trials) and "Connective Tissue Diseases" (2 trials). Many other conditions were trialed in "Hospital Das Clinicas Da Universidade Federal de Goias" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Das Clinicas Da Universidade Federal de Goias
Most popular intervention types in "Hospital Das Clinicas Da Universidade Federal de Goias" are "Drug" (19 trials), "Biological" (3 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "Empagliflozin" (3 trials), "Macitentan 10 mg" (2 trials), "Ralinepag" (2 trials) and "Apixaban" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Das Clinicas Da Universidade Federal de Goias
The vast majority of trials in "Hospital Das Clinicas Da Universidade Federal de Goias" are
23 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Hospital Das Clinicas Da Universidade Federal de Goias
Currently, there are NaN active trials in "Hospital Das Clinicas Da Universidade Federal de Goias".
undefined are not yet recruiting,
6 are recruiting,
4 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 10 completed trials in Hospital Das Clinicas Da Universidade Federal de Goias,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Das Clinicas Da Universidade Federal de Goias, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 21 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".